Antihepatoma activity of the acid and neutral components from ganoderma lucidum

Phytotherapy Research

Volumn 26, Issue 9, 2012, Pages 1294-1300

  Lu, Hui ^a,b   Song, Jie ^a   Jia, Xiao Bin ^a,b   Feng, Liang ^c  

^a KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

antihepatoma activity; Ganoderma lucidum; neutral component

Indexed keywords

4 DEHYDROXY N (4,5 METHYLENEDIOXY 2 NITROBENZYLIDINE)TYRAMINE; 5 METHYL 2 TRIMETHYLSILYLOXYACETOPHENONE; 7,22 ERGOSTADIENONE; 8 METHYL 6 NONENAMIDE; ACID COMPONENT; CYCLOPHOSPHAMIDE; GANODERIC ACID A; GANODERIC ACID B; GANODERIC ACID C2; GANODERIC ACID D; GANODERIC ACID G; GANODERIC ACID H; GANODERIC ACID K; GANODERMA LUCIDUM EXTRACT; LUCIDENIC ACID D; NATURAL PRODUCT; NEUTRAL COMPONENT; OLEIC ACID; PALMITIC ACID; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CHEMICAL COMPOSITION; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PHYTOCHEMISTRY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MATERIA MEDICA; MICE; REISHI;

GANODERMA LUCIDUM; MUS;

EID: 84866064816     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3711     Document Type: Article

References (29)

1. Boh B, Berovic M, Zhang J, et al,. 2007. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13: 265-301.
2. Chang UM, Li CH, Lin LI, et al,. 2006. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 79: 1129-1139.
3. Chen YK, Kuo YH, Chiang BH, et al,. 2009. Cytotoxic activities of 9,11-dehydroergosterol peroxide and ergosterol peroxide from the fermentation mycelia of Ganoderma lucidum cultivated in the medium containing leguminous plants on Hep 3B cells. J Agric Food Chem 57: 5713-5719.
4. Cheng CR, Yang M, Wu ZY, et al,. 2011. Fragmentation pathways of oxygenated tetracyclic triterpenoids and their application in the qualitative analysis of Ganoderma lucidum by multistage tandem mass spectrometry. Rapid Commun Mass Spectrom 25: 1323-1335.
5. Cheng CR, Yue QX, Wu ZY, et al,. 2010. Cytotoxic triterpenoids from Ganoderma lucidum. Phytochemistry 71: 1579-1585.
6. Fukuzawa M, Yamaguchi R, Hide I, et al,. 2008. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull 31: 1933-1937.
7. Gan KH, Kuo SH, Lin CN,. 1998. Steroidal constituents of Ganoderma applanatum and Ganoderma neo-japonicum. J Nat Prod 61: 1421-1422.
8. Gao JJ, Hirakawa A, Min BS, et al,. 2006. In vivo antitumor effects of bitter principles from the antlered form of fruiting bodies of Ganoderma lucidum. J Nat Med 60: 42-48.
9. Gao JJ, Nakamura N, Min BS, et al,. 2004. Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high performance liquid chromatography and its application to the evaluation of ganoderma products. Chem Pharm Bull 52: 688-695.
10. González AG, Leõn F, Rivera A, et al,. 1999. Lanostanoid triterpenes from Ganoderma lucidum. J Nat Prod 62: 1700-1701.
11. Guan SH, Xia JM, Yang M, et al,. 2008. Cytotoxic lanostanoid triterpenes from Ganoderma lucidum. J Asian Nat Prod Res 10: 705-710.
12. Harhaji Trajković LM, Mijatović SA, Maksimović- Ivanić DD, et al,. 2009. Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo. Nutr Cancer 61: 696-707.
13. Ko HH, Hung CF, Wang JP, et al,. 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 69: 234-239.
14. Lin CH, Hsiao YM, Ou CC, et al,. 2010. GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor α-induced expression of matrix metalloproteinase 9 via NF-κB pathway in human alveolar epithelial A549 cells. J Agric Food Chem 58: 12014-12021.
15. Lin SB, Li CH, Lee SS, et al,. 2003. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72: 2381-2390.
16. Lin ZB,. 2005. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99: 144-153.
17. Min BS, Gao JJ, Nakamura N, et al,. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem Pharm Bull 48: 1026-1033.
18. Min BS, Nakamura N, Miyashiro H, et al,. 1998. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull 46: 1607-1612.
19. Russo A, Cardile V, Piovanoc M, et al,. 2010. Pro-apoptotic activity of ergosterol peroxide and (22E)-ergosta-7,22-dien-5α-hydroxy-3,6-dione in human prostate cancer cells. Chem Biol Interact 184: 352-358.
20. Sanodiya BS, Thakur GS, Baghel RK, et al,. 2009. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 10: 717-742.
21. Shang DJ, Li Y, Wang C, et al,. 2011. A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep 25: 267-272.
22. Thyagarajan A, Jedinak A, Nguyen H, et al,. 2010. Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 62: 630-640.
23. Wang XM, Yang M, Guan SH, et al,. 2006. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J Pharm Biomed Anal 41: 838-844.
24. Weng CJ, Yen GC,. 2010. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis 27: 361-369.
25. Yang HL,. 2005. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402. Biotechnol Lett 27: 835-838.
26. Yang M, Wang X, Guan S, et al,. 2007. Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 18: 927-939.
27. Yue QX, Cao ZW, Guan SH, et al,. 2008. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 7: 949-961.
28. Yue QX, Song XY, Ma C, et al,. 2010. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine 17: 606-613.
29. Yuen JWM, Gohel MDI,. 2005. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53: 11-17.